Armata Pharmaceuticals Inc. Company Profile
NYSE: ARMPHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 3.86 +0.26%
Armata Pharmaceuticals at a glance
Armata Pharmaceuticals Inc. (NYSE: ARMP) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Los Angeles, CA. Armata Pharmaceuticals is led by Dr. Deborah L. Birx M.D. and employs about 61 people. At a market capitalization of $141.7 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0000921114, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Armata Pharmaceuticals do?
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.
Business description based on the company's public filings.
Company information
- Legal name
- Armata Pharmaceuticals Inc.
- Ticker
- NYSE: ARMP
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Dr. Deborah L. Birx M.D.
- Employees
- 61
- Headquarters
- 5005 McConnell Avenue, Los Angeles, CA, United States
- Phone
- 310 665 2928
- Website
- armatapharma.com
- Market cap
- $141.66M
- SEC CIK
- 0000921114
Companies similar to Armata Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AVXLAnavex Life Sciences Corp. | 1.54 | +0.65% | $142.75M | vs ARMP |
| MOLNMolecular Partners AG ADR | 3.81 | 0.00% | $145.94M | vs ARMP |
| OTLKOutlook Therapeutics Inc. | 0.564 | -4.41% | $137.30M | vs ARMP |
| VYGRVoyager Therapeutics Inc. | 2.37 | -4.05% | $146.03M | vs ARMP |
| ABOSAcumen Pharmaceuticals Inc. | 2.10 | 0.00% | $151.87M | vs ARMP |
| TARAProtara Therapeutics Inc. | 2.65 | +2.32% | $156.60M | vs ARMP |
| CRDLCardiol Therapeutics Inc. Class A | 1.30 | -1.52% | $157.97M | vs ARMP |
| HUMAHumacyte Inc. | 0.4471 | -5.34% | $124.20M | vs ARMP |